NL-OMON26044已完成不适用
Immunogenicity and safety of intradermal injection of reduced dose Inactivated Poliovirus vaccine (IPV) with a jet injector in healthy adults.
etherlands Vaccine Institute RIVM, formerly Nederland Vaccine, Institute (NVI)0 个研究点目标入组 120 人开始时间: 待定最近更新:
适应症
试验速览
- 阶段
- 不适用
- 状态
- 已完成
- 发起方
- 入组人数
- 120
研究概览
简要总结
/A
研究设计
- 研究类型
- Interventional
入排标准
入选标准
- •1. Age ¡Ý 18 years;
- •2. Good health according to the investigator;
排除标准
- •1. IPV booster dose after 10 years of age;
- •2. OPV dose;
研究者
相似试验
已完成
2 期
Immunogenicity and safety of intradermal injection of reduced dose Inactivated Poliovirus vaccine (IPV) with a jet injector in healthy adultsinfantile paralysispolio10047438NL-OMON32437ederlands Vaccin Instituut120
进行中（未招募）
不适用
Immunogenicity and safety of intradermal injection of reduced dose Inactivated Poliovirus vaccine (IPV) with a jet injector in healthy adults - Intradermal injection of reduced dose IPV in adultsEUCTR2009-015175-27-NLetherlands Vaccine Institute
招募中
4 期
Intradermal booster COVID-19 vaccinatioIntradermal mRNA-based vaccine following the 2-dose primary series of ChAdOx1 (AstraZeneca) can provide a sufficient level of immunity against SAR-CoV-2booster vaccine, third dose, SAR-CoV2, older adultTCTR20220112002Faculty of Medicine Siriraj Hospital, Mahidol University210
已完成
不适用
Immunogenicity and safety of an intradermal boost in healthy general population; preliminary study. (COVID-19)TCTR20211004001faculty of medicine, Prince of songkla university240
已完成
3 期
The saftey and efficacy of intradermal injection of type A butulinum toxin in chemotherapy induced peripheral neuropathyChemotherapy induced neuropathy.IRCT20200425047202N1Shahid Beheshti University of Medical Sciences40